Condition: Tuberculosis · Immunologic Activity Alteration · Sponsor: Linkoeping University
The goal of this observational study is to learn about how the blood leucocytes from patients with and without exposure or disease from tuberculosis (TB) are able to kill live mycobacteria (M. tuberculosis). The main question it aims to answer is: Is intracellular growth suppression of M. tuberculosis in peripheral blood mononuclear cells variable among healthy blood donors and higher than in patients with latent TB compared to active TB?
This description comes directly from the study's public registry record.
Thomas Schoen, Professor · +48013580000 · tschon@hotmail.com
Always discuss trial participation with your own doctor first.
| Kalmar County Hospital | Kalmar, Sweden | Recruiting |
| Dept of Infectious Diseases | Linköping, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06580639